Stefanie Kraff

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Markus Joerger, Joachim von Pawel, Stefanie Kraff et al. · Annals of Oncology · 2016 · 85 citations

Oncology, Medicine, Metronomic Therapy +5

BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics

Dirk Thomas, Kirstin Thelen, Stefanie Kraff et al. · Research and Practice in Thrombosis and Haemostasis · 2019 · 76 citations · Full text

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Martin Wilhelm, Lothar Mueller, Michael Craig Miller et al. · Clinical Colorectal Cancer · 2016 · 65 citations

Oncology, Gastrointestinal Oncology, Medicine +8

Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring

Markus Joerger, Stefanie Kraff, Alwin D. R. Huitema et al. · Clinical Pharmacokinetics · 2012 · 56 citations

Precision Dosing, Drug Safety, Therapeutic Drug Monitoring +9

Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

Thomas Horvatits, Reinhard Kitzberger, Andreas Drolz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 36 citations · Full text